Apretude (cabotegravir) is a long-acting injection used to lower the risk of getting an HIV infection in people at risk. It's an antiviral medication that's FDA approved for pre-exposure prophylaxis (PrEP), which means it helps prevent HIV before you're exposed to it. The injection is typically given every other month as a shot in the buttock muscle by a healthcare professional. The most common side effects are injection site reactions like pain, redness, and hardening of the skin.
HIV pre-exposure prophylaxis (PrEP)
Apretude (cabotegravir) is an integrase inhibitor. It works by blocking an enzyme (protein) called integrase that HIV uses to insert its genetic material into your cells. By stopping this step, the virus can't cause an infection in your body.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Only FDA-approved injection for HIV PrEP
After the first two doses, only need to get an injection every other month
Works well at reducing the risk of HIV infection
Commonly causes pain at the injection site
Must be injected in the buttock muscle
Requires regular visits to a healthcare professional for injections
In addition to getting Apretude (cabotegravir) injections, it's important to take other steps to lower your risk of HIV. These include using condoms during sex, knowing your partner’s HIV status, and getting tested regularly for sexually transmitted infections (STIs).
It’s important to get your Apretude (cabotegravir) injections on time for them to work best. If you miss a dose, your prescriber will decide whether to continue or switch your medication. You might need extra doses depending on how late your shot was.
If you know you’ll miss your Apretude (cabotegravir) injection by more than 7 days, your prescriber might recommend Vocabria (cabotegravir) tablets. This tablet can be taken to cover the gap, but only for up to 2 months.
Let your prescriber know if you have HIV symptoms, like fever, muscle pain, tiredness, or rash so you can be tested right away. Apretude (cabotegravir) is only for prevention — it doesn't treat HIV.
If you decide to stop taking Apretude (cabotegravir) but still have HIV risk, talk to your prescriber within 2 months of your last shot. They can help you switch to another option to stay protected.
Apretude (cabotegravir) is a long-acting injection that can stay in your body for 12 months or longer after your last dose. Because it stays in your system for a long time, talk to your prescriber before stopping so you can make a plan and lower your risk of getting HIV.
Apretude (cabotegravir) can interact with other medications. Tell your care team about all prescriptions, over-the-counter medications, and supplements you take before starting.
Call your care team if you get a rash while taking Apretude (cabotegravir). Get medical help right away if the rash comes with fever, blisters, swelling, or trouble breathing. These could be signs of a serious allergic reaction, and you might need to stop receiving the medication.
If you’re breastfeeding, talk with your care team about the risks and benefits of taking Apretude (cabotegravir). This medication can stay in your body for up to 12 months, and small amounts might pass to your baby.
Apretude (cabotegravir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Apretude (cabotegravir) can help lower your risk of getting HIV, but it works best when used with other protection methods. This includes getting your injections on time and practicing safer sex, like using condoms and getting tested regularly for STIs.
Before starting Apretude (cabotegravir), your prescriber might ask you about any recent situations where you could have been exposed to HIV — like unprotected sex or a recent STI. You'll also need to take an HIV test before each injection. Let your prescriber know if you have symptoms of HIV, such as fever, feeling tired, muscle pain, and skin rash, either before or during treatment.
There’s a chance that HIV could become harder to treat if you get infected before, during, or shortly after stopping Apretude (cabotegravir). To help prevent this, your prescriber will test you for HIV before each injection to make sure you’re still HIV-negative. If you test positive, you’ll need to switch to full HIV treatment.
If you stop getting Apretude (cabotegravir) but are still at risk for HIV, your prescriber might recommend another type of PrEP. It's best to start the new medication within 2 months after your last injection.
Apretude (cabotegravir) can stay in your body for up to 12 months or longer after your last injection. That’s why it’s important to get your shots on time every 2 months. Missing doses can raise your risk of getting HIV and make the virus harder to treat if you do get infected.
Some people have had serious allergic reactions while taking cabotegravir, the active ingredient in Apretude (cabotegravir). In rare cases, these reactions have included serious skin problems like Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). In studies, some people started with Vocabria (cabotegravir) tablets first to help spot early signs of a reaction before getting injections. Stop taking the medication right away and call your care team if you get a severe rash or a rash with other symptoms like fever, feeling very tired, muscle or joint pain, blisters, mouth sores, red or irritated eyes, facial swelling, or trouble breathing.
Liver problems have been reported in some people taking Apretude (cabotegravir), even in those without known liver issues. Your prescriber might check your liver with blood tests during treatment to watch for any signs of damage. Call your prescriber right away if you notice signs of liver problems like pain in the upper right side of your stomach, yellowing of your skin or eyes, dark urine, pale stools, nausea, vomiting, loss of appetite, or itching.
Mood changes, including depression and suicidal thoughts of behavior, have been reported in some people taking Apretude (cabotegravir). If you or someone close to you notices any changes in your mood, call your prescriber right away. They will help decide if it’s safe for you to keep taking Apretude (cabotegravir).
Apretude (cabotegravir) can interact with many other medications. These interactions can lead to side effects, making the medication not work as it should for preventing HIV. Before and while taking Apretude (cabotegravir), tell your prescriber about everything you take — prescription, over-the-counter products, and supplements — so they can help manage any possible interactions.
Apretude (cabotegravir) is approved for adults and teens ages 12 and older, weighing at least 35 kg (77 lbs).
The typical starting dose is one 600 mg injection into the buttock muscle once a month for 2 months. After that, the maintenance dose is one 600 mg injection once every 2 months.
*Note: You might need to take Vocabria (cabotegravir) tablets for about a month before receiving Apretude (cabotegravir) injections.
Have a positive or unknown HIV status
Taking certain seizure medications that cause Apretude (cabotegravir) to not work as well (e.g., carbamazepine, oxcarbazepine, phenobarbital, phenytoin)
Taking certain antibiotics that cause Apretude (cabotegravir) to not work as well (e.g., rifampin, rifapentine)
Treatment of HIV infection
Prevention of HIV infection (PrEP or pre-exposure prophylaxis)
Treatment of HIV infection
Prevention of HIV infection (PrEP) through sexual intercourse, except for receptive vaginal sex
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.